Literature DB >> 3743309

Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota.

D J Ballard, L J Melton, M S Dwyer, J C Trautmann, C P Chu, W M O'Fallon, P J Palumbo.   

Abstract

Retinopathy is an important sequela of diabetes mellitus, but clinical risk factors for this condition have rarely been assessed in a geographically defined population. In this population-based study, the 1135 Rochester, Minnesota, residents with diabetes mellitus initially diagnosed between 1945 and 1969 (incidence cohort) were followed through their complete medical records in the community to January 1, 1982. Because most of the cases of diabetic retinopathy in Rochester residents developed in patients with non-insulin-dependent diabetes mellitus (NIDDM), risk factors for diabetic retinopathy were examined in this group (N = 1031). A proportional hazards model identified the following risk factors for diabetic retinopathy in NIDDM: elevated initial fasting blood glucose level, marked obesity, and earlier age at onset of diabetes. Stratified analyses indicated that duration of diabetes was also significantly associated with an increased risk of retinopathy. Two secular trends, increasing detection of "mild" NIDDM and decreasing risk of diabetic retinopathy, had a major effect on retinopathy risk assessment. These data also suggest that insulin therapy is not an independent risk factor for diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743309     DOI: 10.2337/diacare.9.4.334

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  28 in total

1.  Blood pressure control and diabetic retinopathy.

Authors:  R Klein; B E K Klein
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign.

Authors:  Hoon Park; Young Gyun Kim; Jong Wook Lee; Jong Seok Park
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

3.  Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project.

Authors:  R McKay; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

Review 4.  The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis.

Authors:  Xiaoling Cai; Yifei Chen; Wenjia Yang; Xueying Gao; Xueyao Han; Linong Ji
Journal:  Endocrine       Date:  2018-08-20       Impact factor: 3.633

5.  Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.

Authors:  G Pugliese; R G Tilton; A Speedy; K Chang; E Santarelli; M A Province; D Eades; W R Sherman; J R Williamson
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

6.  Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes.

Authors:  S C Brailsford; R Davies; C Canning; P J Roderick
Journal:  Health Care Manag Sci       Date:  1998-10

Review 7.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

Review 8.  Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.

Authors:  Sylvia M C Vijgen; Mirjam Hoogendoorn; Caroline A Baan; G Ardine de Wit; Wien Limburg; Talitha L Feenstra
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

9.  Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.

Authors:  Q Z Liu; D J Pettitt; R L Hanson; M A Charles; R Klein; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

Review 10.  Influence of the degree of control of diabetes on the prevention, postponement and amelioration of late complications.

Authors:  B R Zimmerman
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.